About ArtusLabs
ArtusLabs is a company based in Durham (United States) founded in 2007 was acquired by PerkinElmer in March 2011. ArtusLabs has raised $3.68 million across 3 funding rounds from investors including PerkinElmer. ArtusLabs operates in a competitive market with competitors including Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.68 M (USD)
in 3 rounds
-
Latest Funding Round
$600 K (USD), Debt – Conventional
Sep 23, 2010
- Investors
-
Employee Count
Not available
-
Acquired by
PerkinElmer
(Mar 24, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ArtusLabs
ArtusLabs has successfully raised a total of $3.68M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $600 thousand completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ArtusLabs
ArtusLabs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Locked | Locked | Locked |
Investor details for ArtusLabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ArtusLabs
Investment portfolio details for ArtusLabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ArtusLabs
Detailed financials for ArtusLabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artuslabs Comparisons
Peer comparison for ArtusLabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ArtusLabs
ArtusLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based data-mining tools for scientific evidence discovery are provided.
|
|
| Locked | Locked | Locked |
Provider of AI solutions transforming medical text into enriched healthcare data
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
AI based drug purposing platform to identify treatments for rare diseases
|
|
| Locked | Locked | Locked |
Research communication services are provided to boost visibility and impact.
|
|
| Locked | Locked | Locked |
Medical news and research are personalized for physicians.
|
Detailed competitors of ArtusLabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artuslabs
Complete news archive for ArtusLabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ArtusLabs
ArtusLabs was founded in 2007 and raised its 1st funding round 3 years after it was founded.
ArtusLabs is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
ArtusLabs is a funded company, having raised a total of $3.68M across 3 funding rounds to date.
ArtusLabs was founded in 2007 and is based in Durham, United States. Software solutions for data management are offered by the company, targeting workplace collaboration and drug discovery processes. Tools such as social networking features, collaboration platforms, and scientific data mining capabilities are included to support research communication and management for internal and external users. Operations center on the biotechnology and software sectors.
ArtusLabs's top competitors include Causaly, ScienceIO and BioSymetrics.
ArtusLabs has 1 investor. Key investors include PerkinElmer.